Equities Analysts Set Expectations for PAHC Q4 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research raised their Q4 2025 earnings per share estimates for Phibro Animal Health in a report released on Wednesday, February 19th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.50 per share for the quarter, up from their prior estimate of $0.43. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2026 earnings at $0.53 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $1.91 EPS, Q2 2027 earnings at $0.55 EPS and FY2027 earnings at $2.17 EPS.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.

Several other research firms have also recently weighed in on PAHC. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Barclays boosted their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Down 5.0 %

PAHC stock opened at $22.97 on Friday. Phibro Animal Health has a 1-year low of $11.90 and a 1-year high of $26.55. The business has a fifty day moving average price of $22.21 and a 200-day moving average price of $22.07. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock has a market capitalization of $930.29 million, a P/E ratio of 47.85, a P/E/G ratio of 0.47 and a beta of 0.52.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s payout ratio is currently 100.00%.

Institutional Trading of Phibro Animal Health

Several large investors have recently modified their holdings of PAHC. Sterling Capital Management LLC grew its holdings in Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock valued at $394,000 after purchasing an additional 448 shares during the period. Rhumbline Advisers grew its holdings in Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC grew its holdings in Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after purchasing an additional 503 shares during the period. BNP Paribas Financial Markets grew its holdings in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the period. Finally, New York State Teachers Retirement System grew its holdings in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the period. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.